06/01/2015
https://congress.gov...
"These are choices Americans simply should not have to make."
"the committee begins the process of fulfilling our commitment to provide some much-needed relief to Americans struggling to pay for skyrocketing prescription drugs."
"One way to achieve this goal is to facilitate greater competition from generic and biosimilar manufacturers."
"It is unacceptable and could, in fact, lead to greater illness and higher medical costs down the road."